Eyegate Pharma (EYEG) Reports First Patient Enrollment in PRK Pilot Study
Tweet Send to a Friend
EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) today announced that the first patient has been enrolled in its pilot study evaluating the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
